Global IVD Contract Manufacturing Market Size Study & Forecast, by Device Type (Consumables, Equipment) by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation) and Service (Manufacturing, Assay Develop

The Global IVD Contract Manufacturing Market is valued at approximately USD 14.2 billion in 2024 and is projected to expand at a robust CAGR of 11.50% during the forecast period 2025-2035. IVD contract manufacturing encompasses the outsourcing of production and assay development for in-vitro diagnostic devices, allowing companies to leverage specialized manufacturing expertise, ensure regulatory compliance, and optimize cost-efficiency. The growing emphasis on diagnostic testing, increasing prevalence of chronic diseases, and rising demand for rapid, reliable diagnostic solutions are driving the market’s expansion. Technological advancements in molecular diagnostics and immunoassay platforms, coupled with strategic partnerships and collaborations, further propel market growth globally.

The intensifying focus on precision diagnostics and scalable production has led to a surge in demand for IVD contract manufacturing services. With hospitals, diagnostic laboratories, and biotech firms seeking specialized contract partners to streamline production and enhance assay performance, the market is witnessing significant traction. According to recent industry data, global demand for in-vitro diagnostic tests continues to accelerate, underpinned by the need for early disease detection and personalized medicine. Simultaneously, increasing regulatory complexities and the high cost of advanced diagnostic platforms challenge market participants, shaping the competitive landscape throughout the forecast period.

The detailed segments and sub-segments included in the report are:

By Device Type:
• Consumables
• Equipment

By Technology:
• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Coagulation

By Service:
• Manufacturing
• Assay Development

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Consumables Segment Expected to Dominate the Market

Consumables represent the dominant device type segment, primarily due to their recurring demand across diagnostic laboratories and healthcare facilities. The segment’s preeminence is supported by high-volume usage, the continuous need for reagent kits, and advancements in consumable technologies that enhance assay sensitivity and throughput. As laboratories increasingly adopt automated workflows, the demand for high-quality consumables continues to accelerate, solidifying its market leadership.

Immunoassay Technology Leads in Revenue Contribution

Currently, immunoassay-based diagnostics account for the largest revenue share, attributed to their widespread application in detecting infectious diseases, hormones, and biomarkers. This technology benefits from extensive clinical validation, broad adoption across laboratories, and continuous innovation in multiplexed assay formats, making it the principal revenue driver within the IVD technology segment.

The Global IVD Contract Manufacturing Market exhibits substantial regional variation, with North America leading due to advanced healthcare infrastructure, stringent quality standards, and high adoption of cutting-edge diagnostic technologies. Europe maintains a significant presence supported by strong regulatory frameworks and established diagnostic manufacturing hubs. Asia Pacific is anticipated to emerge as the fastest-growing market owing to increasing healthcare expenditure, expansion of diagnostic laboratories, and rising prevalence of chronic and infectious diseases. Latin America and the Middle East & Africa are gradually increasing their market share, fueled by growing diagnostic awareness and strategic investments in manufacturing partnerships.

Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Agilent Technologies, Inc.
• Roche Diagnostics
• Siemens Healthineers
• PerkinElmer, Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Abbott Laboratories
• Lonza Group AG
• Wuxi AppTec
• Maccura Biotechnology
• Greiner Bio-One International
• Sysmex Corporation

Global IVD Contract Manufacturing Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments and countries in recent years and to forecast the values for the coming years. The report incorporates both qualitative and quantitative aspects of the industry, providing detailed insights into growth drivers, market challenges, and emerging opportunities. Additionally, it highlights competitive dynamics, key strategies of leading players, and prospective investment opportunities in micro-markets.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level insights.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more